333 related articles for article (PubMed ID: 14768605)
1. Generic drugs. Save money--but is there a cost?
Roberts SS
Diabetes Forecast; 2002 Nov; 55(11):51-3. PubMed ID: 14768605
[No Abstract] [Full Text] [Related]
2. Generic drugs versus brand names: switching could save money. Generic drugs have to go through the same FDA approvals as brand names, so they have the same quality.
Harv Womens Health Watch; 2013 Jul; 20(11):3. PubMed ID: 24818274
[No Abstract] [Full Text] [Related]
3. Generic drugs: an overview.
Helgeland D
S D Med; 2006 Apr; 59(4):161-3. PubMed ID: 16681165
[No Abstract] [Full Text] [Related]
4. The generic drug approval process.
Rheinstein PH
Am Fam Physician; 1993 Dec; 48(8):1357-60. PubMed ID: 8249762
[No Abstract] [Full Text] [Related]
5. Prescribing generic antiepileptic drugs: Issues and concerns for nurse practitioners.
Barrett MW
J Am Acad Nurse Pract; 2010 Jun; 22(6):300-4. PubMed ID: 20536627
[TBL] [Abstract][Full Text] [Related]
6. Generic Drugs.
Med Lett Drugs Ther; 2002 Oct; 44(1141):89-90. PubMed ID: 12405134
[No Abstract] [Full Text] [Related]
7. Generic products of antiepileptic drugs (AEDs): is it an issue?
Bialer M
Epilepsia; 2007 Oct; 48(10):1825-32. PubMed ID: 17850324
[TBL] [Abstract][Full Text] [Related]
8. Generic prescribing--cost saving chaos.
Jackson G
Int J Clin Pract; 2005 Feb; 59(2):125. PubMed ID: 15854183
[No Abstract] [Full Text] [Related]
9. [Generics: essentially similar, bioequivalent but not identical].
Even-Adin D; De Muylder JA; Sternon J
Rev Med Brux; 2001 Dec; 22(6):513-20. PubMed ID: 11811047
[TBL] [Abstract][Full Text] [Related]
10. Initial responses to recommendations of the Blue Ribbon Committee on Generic Medicines.
Heller WM
Am J Hosp Pharm; 1993 Feb; 50(2):318-22. PubMed ID: 8480792
[No Abstract] [Full Text] [Related]
11. FDA drug list: key to generic substitution.
FDA Consum; 1979 Feb; 13(1):15-7. PubMed ID: 10308816
[TBL] [Abstract][Full Text] [Related]
12. Saving money on your prescription drugs.
Johns Hopkins Med Lett Health After 50; 2010 Jan; 21(11):4-5. PubMed ID: 20336846
[No Abstract] [Full Text] [Related]
13. Current approaches to the use of generic antiepileptic drugs.
Krämer G; Biraben A; Carreno M; Guekht A; de Haan GJ; Jedrzejczak J; Josephs D; van Rijckevorsel K; Zaccara G
Epilepsy Behav; 2007 Aug; 11(1):46-52. PubMed ID: 17537678
[TBL] [Abstract][Full Text] [Related]
14. [Generic antiarrhythmics: safety and efficacy versus cost].
Katz A; Zalzstein E
Harefuah; 2001 Nov; 140(11):1087-90. PubMed ID: 11759388
[No Abstract] [Full Text] [Related]
15. Generic and alternative brand-name pharmaceutical equivalents: select with caution.
Hendeles L; Hochhaus G; Kazerounian S
Am J Hosp Pharm; 1993 Feb; 50(2):323-9. PubMed ID: 8480793
[No Abstract] [Full Text] [Related]
16. Bioequivalence/bioavailability retention samples.
Ransom C
Qual Assur; 1993; 2(1-2):42-3. PubMed ID: 8156218
[No Abstract] [Full Text] [Related]
17. Perspectives. Drug formularies pose legal threat to providers.
Moskowitz DB
Faulkner Grays Med Health; 1995 Feb; 49(6):suppl 1-4. PubMed ID: 10139750
[No Abstract] [Full Text] [Related]
18. US biotech prepares to fight generic biologics.
Reid B
Nat Biotechnol; 2002 Apr; 20(4):322. PubMed ID: 11923820
[No Abstract] [Full Text] [Related]
19. What's the problem with generic antiepileptic drugs?: a call to action.
Berg MJ
Neurology; 2007 Apr; 68(16):1245-6. PubMed ID: 17438211
[No Abstract] [Full Text] [Related]
20. [Original or generic?].
Magyar IG
Neuropsychopharmacol Hung; 2005 Dec; 7(4):167-8. PubMed ID: 16496480
[No Abstract] [Full Text] [Related]
[Next] [New Search]
